1 / 3

Prefilled Syringes Market to Witness Robust Growth in Coming Years

The global prefilled syringes market attained a value of $1,914.1 million in 2020, and it is predicted to progress at a CAGR of 6.8% between 2021 and 2030. Furthermore, the market is predicted to reach a revenue of $3,646.7 million by 2030. The factors fueling the expansion of the market are the surging concerns raised over the prevalence of needlestick injuries, various advantages of prefilled syringes over conventional vial and syringe packaging systems, and the burgeoning requirement for point-of-care administration.

Download Presentation

Prefilled Syringes Market to Witness Robust Growth in Coming Years

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Prefilled Syringes Market to Reach $7.5 Billion by 2023 © P&S Intelligence. All rights reserved Page 1

  2. In 2017, the global prefilled syringes market reached $4.7 billion and is projected to register an 8.3% CAGR during the forecast period (2018–2023). The market is growing because of the extensive pipeline of injectable drugs, rising demand for injectable pharmaceutical products, expanding pharmaceutical industry, increasing prevalence of chronic and lifestyle associated diseases, surging requirement for point-of-care administration, benefits of prefilled syringes over conventional vial and syringe packaging systems, regulations associated with needlestick injuries, and technological advancements. A single dose of disposable syringe containing parenteral drug filled by the manufacturers is called prefilled syringe. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/prefilled- syringes-market/report-sample On the basis of application, the prefilled syringes market is categorized into anaphylaxis, diabetes, rheumatoid arthritis, and others (which include psoriasis, multiple sclerosis, anemia, and diarrhea). The diabetes application held the largest share of the market during the historical period. The reason for this is the surging prevalence of diabetes around the globe. According to the World Health Organization (WHO), the prevalence of diabetes among adults (above 18 years) rose from 4.7% in 1980 to 8.5% in 2014. The category is further expected to register the highest CAGR of 9.0% during the forecast period. Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry- url=prefilled-syringes-market The surging prevalence of chronic and lifestyle associated diseases is among the primary driving factors of the prefilled syringes market. The prevalence of diseases including cancer, cardiovascular diseases, diabetes, and respiratory diseases is increasing because of lack of access to preventive care and changing lifestyle, particularly in developing countries. Attributed to this surging patient base, the manufacturers are increasingly focusing on the development of several types of prefilled syringes with varied doses and drug composition for the treatment of these diseases, which is resulting in the growth of the market. A key trend being witnessed in the prefilled syringes market is the growing adoption of customized prefilled syringes. Injectable formulations require stringent quality control for meeting the requirements of customers. The manufacturers have started focusing on the development of prefilled syringes which can be utilized by individuals on their own. The focus of manufacturers is thus shifting from syringes utilized by hospitals or other healthcare providers to self-administration dose syringes. These syringes are customized, and thus are designed according to the medication and dosage needed by the patient. © P&S Intelligence. All rights reserved Page 2

  3. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved Page 3

More Related